<?xml version="1.0" encoding="UTF-8"?>
<p>Depending on the results at the end of the studies, we may contact participants to enable long-term follow-up of immunogenicity for the different trials. The long-term follow-up will depend on the initial data from this primary study. An amendment to the protocol with details of any planned long-term follow up will be made and submitted to the various regulatory authorities for review and approval.</p>
